Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/28/18 → 8/27/22 |
Funding
- Merck Sharp & Dohme Corporation: $70,221.53
Comprehensive Analysis of CMV-specific T cells in Human Subjects Receiving a Replication-defective Human Cytomegalovirus Vaccine
- Rupp, Richard (PI)
Project: Other project